Cambridge Investment Research Advisors’s BioNexus Gene Lab BGLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,296
Closed -$6K 3477
2024
Q3
$6K Buy
+1,296
New +$6K ﹤0.01% 3397